Placebo News and Research

RSS

Unvaccinated white evangelicals seem to be resistant to persuasive pro-vaccine messages

White evangelical Christians have resisted getting vaccinated against COVID-19 at higher rates than other religious groups in the United States. A new study by Yale researchers provides evidence that persuading these vaccine holdouts to get their shots has only gotten more difficult.

30 Nov 2021

Study compares NAbs from natural SARS-CoV-2 infection vs. vaccine induced against symptomatic infection

Scientists have recently compared the levels of antibody concentrations in unvaccinated, SARS-CoV-2 convalescent individuals and COVID-19 specific antibodies in vaccinated individuals.

30 Nov 2021

Teriflunomide tempers lesion growth in pediatric patients with multiple sclerosis

There are few treatment options for children with multiple sclerosis - a condition in which the immune system attacks the protective covering of nerves in the brain and spinal cord - and most therapies for the disease have not been tested in children.

30 Nov 2021

Heart failure patients may benefit from common type 2 diabetes drug

Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved symptoms and physical limitations in patients with heart failure with preserved ejection fraction, according to clinical trial results published in Nature Medicine.

29 Nov 2021

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

Researchers conducted a Phase II randomized placebo-controlled, double-blinded trial between July 8, 2020, and March 23. 2021.

28 Nov 2021

Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine

A study developed a protein-based subunit vaccine, PHH-1V, that consisted of a recombinant RBD fusion heterodimer of the alpha) and beta variants of SARS-CoV-2.

26 Nov 2021

Researchers investigate Moderna COVID-19 vaccine efficacy

Researchers have been investigating the vaccine efficacy of the mRNA-1273 vaccine.

25 Nov 2021

Success of covid antiviral pills hinges on access to speedy and accurate tests

Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic — with a second option from Pfizer to follow shortly after.

22 Nov 2021

TXA drug has minimal impact in controlling blood loss in severely injured trauma patients

A recent study found that the drug tranexamic acid has minimal impact in controlling blood loss in severely injured trauma patients at the standard doses given, according to researchers at Washington University School of Medicine in St. Louis.

21 Nov 2021

Can you take the COVID-19 and Influenza vaccines on the same day?

Scientists have conducted a substudy within a phase 3 UK trial and have reported the safety, immunogenicity, and efficacy of the NVX-CoV2373 COVID-19 vaccine when co-administered with licensed seasonal influenza vaccines.

19 Nov 2021

REGEN-COV is effective in preventing severe COVID-19 in immunocompromised individuals

A recent study assesses the efficacy of repeat doses of REGEN-COV in SARS-CoV-2-negative adults who were healthy or had chronic medical conditions.

18 Nov 2021

Drug improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy

Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from a recent clinical trial published in Nature Medicine.

16 Nov 2021

Study: Daily low-dose aspirin is neither protective nor harmful regarding dementia risk

Taking daily low-dose aspirin for seven years did not affect the risk of dementia or mental decline among adults with type 2 diabetes, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Oral PCSK9-inhibitor highly effective at reducing high levels of LDL cholesterol, studies show

Results from two early clinical studies show the first version of an oral PCSK9-inhibitor cholesterol-lowering medicine was well tolerated and highly effective at reducing high levels of LDL cholesterol, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Prescription omega-3 pill did not reduce hospitalization or death from COVID-19

A high dose of a purified omega-3 fatty acid, available by prescription only, was well tolerated; however, it did not substantially reduce incidents of hospitalizations and/or deaths among people with COVID-19, according to a late-breaking clinical trial presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Common hypertension drug not effective in slowing down the progression of Alzheimer's disease

New research led by the University of Bristol, has shown the drug losartan, normally used to treat high blood pressure (hypertension), is not effective in slowing down the progression of Alzheimer's disease (AD) in people with mild-to-moderate disease after 12 months of treatment.

15 Nov 2021

Type 2 diabetes medication works effectively, safely in patients hospitalized for acute heart failure

Adults treated with empagliflozin during hospitalization for acute heart failure experienced a clinical benefit such as increased survival, lower risk of heart failure hospital readmission and an overall improvement in their quality of life, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Placebo News and Research

Unvaccinated white evangelicals seem to be resistant to persuasive pro-vaccine messages

Study compares NAbs from natural SARS-CoV-2 infection vs. vaccine induced against symptomatic infection

Teriflunomide tempers lesion growth in pediatric patients with multiple sclerosis

Heart failure patients may benefit from common type 2 diabetes drug

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine

Researchers investigate Moderna COVID-19 vaccine efficacy

Success of covid antiviral pills hinges on access to speedy and accurate tests

TXA drug has minimal impact in controlling blood loss in severely injured trauma patients

Can you take the COVID-19 and Influenza vaccines on the same day?

REGEN-COV is effective in preventing severe COVID-19 in immunocompromised individuals

Drug improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy

Study: Daily low-dose aspirin is neither protective nor harmful regarding dementia risk

Oral PCSK9-inhibitor highly effective at reducing high levels of LDL cholesterol, studies show

Prescription omega-3 pill did not reduce hospitalization or death from COVID-19

Common hypertension drug not effective in slowing down the progression of Alzheimer's disease

Type 2 diabetes medication works effectively, safely in patients hospitalized for acute heart failure

Study provides a new target for therapeutic intervention in Parkinson's disease

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

Study shows 90.7% efficacy for the BNT162b2 COVID vaccine in 5-11 year-olds

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News